Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales

Authors: Hanna E. Tervonen, Richard Walton, Hui You, Deborah Baker, David Roder, David Currow, Sanchia Aranda

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Aboriginal and Torres Strait Islander peoples in Australia have been found to have poorer cancer survival than non-Aboriginal people. However, use of conventional relative survival analyses is limited due to a lack of life tables. This cohort study examined whether poorer survival persist after accounting for competing risks of death from other causes and disparities in cancer stage at diagnosis, for all cancers collectively and by cancer site.

Methods

People diagnosed in 2000–2008 were extracted from the population-based New South Wales Cancer Registry. Aboriginal status was multiply imputed for people with missing information (12.9%). Logistic regression models were used to compute odds ratios (ORs) with 95% confidence intervals (CIs) for ‘advanced stage’ at diagnosis (separately for distant and distant/regional stage). Survival was examined using competing risk regression to compute subhazard ratios (SHRs) with 95%CIs.

Results

Of the 301,356 cases, 2517 (0.84%) identified as Aboriginal (0.94% after imputation). After adjusting for age, sex, year of diagnosis, socio-economic status, remoteness, and cancer site Aboriginal peoples were more likely to be diagnosed with distant (OR 1.30, 95%CI 1.17–1.44) or distant/regional stage (OR 1.29, 95%CI 1.18–1.40) for all cancers collectively. This applied to cancers of the female breast, uterus, prostate, kidney, others (those not included in other categories) and cervix (when analyses were restricted to cases with known stages/known Aboriginal status). Aboriginal peoples had a higher hazard of death than non-Aboriginal people after accounting for competing risks from other causes of death, socio-demographic factors, stage and cancer site (SHR 1.40, 95%CI 1.31–1.50 for all cancers collectively). Consistent results applied to colorectal, lung, breast, prostate and other cancers.

Conclusions

Aboriginal peoples with cancer have an elevated hazard of cancer death compared with non-Aboriginal people, after accounting for more advanced stage and competing causes of death. Further research is needed to determine reasons, including any contribution of co-morbidity, lifestyle factors and differentials in service access to help explain disparities.
Literature
1.
go back to reference Australian Institute of Health and Welfare. Mortality inequalities in Australia 2009–2011. Bulletin no. 124. Cat. no. AUS 184. Canberra: AIHW, 2014. Australian Institute of Health and Welfare. Mortality inequalities in Australia 2009–2011. Bulletin no. 124. Cat. no. AUS 184. Canberra: AIHW, 2014.
2.
go back to reference Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. Cat. no. IHW 42. Canberra: AIHW, 2011. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. Cat. no. IHW 42. Canberra: AIHW, 2011.
3.
go back to reference Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait Islander peoples: the indigenous health gap. Int J Epidemiol. 2009;38:470–7.CrossRefPubMed Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in Aboriginal and Torres Strait Islander peoples: the indigenous health gap. Int J Epidemiol. 2009;38:470–7.CrossRefPubMed
4.
go back to reference Morrell S, You H, Baker D. Estimates of cancer incidence, mortality and survival in Aboriginal people from NSW, Australia. BMC Cancer. 2012;12:168. Morrell S, You H, Baker D. Estimates of cancer incidence, mortality and survival in Aboriginal people from NSW, Australia. BMC Cancer. 2012;12:168.
5.
go back to reference Supramaniam R, Gibberd A, Dillon A, Goldsbury DE, O'Connell DL. Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal women. BMC Cancer. 2014;14:163.CrossRefPubMedPubMedCentral Supramaniam R, Gibberd A, Dillon A, Goldsbury DE, O'Connell DL. Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal women. BMC Cancer. 2014;14:163.CrossRefPubMedPubMedCentral
6.
go back to reference Valery PC, Coory M, Stirling J, Green AC. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet. 2006;367:1842–8. Valery PC, Coory M, Stirling J, Green AC. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet. 2006;367:1842–8.
7.
go back to reference Coory MD, Green AC, Stirling J, Valery PC. Survival of Indigenous and non-Indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study. Med J Aust. 2008;188:562–6. Coory MD, Green AC, Stirling J, Valery PC. Survival of Indigenous and non-Indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study. Med J Aust. 2008;188:562–6.
8.
go back to reference Condon JR, Zhang X, Baade P, Griffiths K, Cunningham J, Roder DM, et al. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul Health Metr. 2014;12:1.CrossRefPubMedPubMedCentral Condon JR, Zhang X, Baade P, Griffiths K, Cunningham J, Roder DM, et al. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul Health Metr. 2014;12:1.CrossRefPubMedPubMedCentral
9.
go back to reference Condon JR, Barnes T, Armstrong BK, Selva-Nayagam S, Elwood JM. Stage at diagnosis and cancer survival for Indigenous Australians in the Northern Territory. Med J Aust. 2005;182:277–80. Condon JR, Barnes T, Armstrong BK, Selva-Nayagam S, Elwood JM. Stage at diagnosis and cancer survival for Indigenous Australians in the Northern Territory. Med J Aust. 2005;182:277–80.
10.
go back to reference Roder D, Webster F, Zorbas H, Sinclair S. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia. Asian Pac J Cancer Prev. 2012;13:147–55.CrossRefPubMed Roder D, Webster F, Zorbas H, Sinclair S. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia. Asian Pac J Cancer Prev. 2012;13:147–55.CrossRefPubMed
11.
go back to reference Chong A, Roder D. Exploring differences in survival from cancer among Indigenous and non-Indigenous Australians: implications for health service delivery and research. Asian Pac J Cancer Prev. 2010;11:953–61. Chong A, Roder D. Exploring differences in survival from cancer among Indigenous and non-Indigenous Australians: implications for health service delivery and research. Asian Pac J Cancer Prev. 2010;11:953–61.
12.
go back to reference Valery PC, Youlden DR, Baade PD, Ward LJ, Green AC, Aitken JF. Cancer survival in Indigenous and non-Indigenous Australian children: what is the difference? Cancer Causes Control. 2013;24:2099–106. Valery PC, Youlden DR, Baade PD, Ward LJ, Green AC, Aitken JF. Cancer survival in Indigenous and non-Indigenous Australian children: what is the difference? Cancer Causes Control. 2013;24:2099–106.
13.
go back to reference Roder D, Currow D. Cancer in Aboriginal and Torres Strait Islander people of Australia. Asian Pac J Cancer Prev 2009;10:729–733. Roder D, Currow D. Cancer in Aboriginal and Torres Strait Islander people of Australia. Asian Pac J Cancer Prev 2009;10:729–733.
14.
go back to reference Cottrell J, Street J, Chong A, Roder D. Comparing cancer profiles and survival of Aboriginal and non-Aboriginal patients in South Australia: where are the opportunities for improving Aboriginal health? Asian Pac J Cancer Prev. 2007;8:495–501.PubMed Cottrell J, Street J, Chong A, Roder D. Comparing cancer profiles and survival of Aboriginal and non-Aboriginal patients in South Australia: where are the opportunities for improving Aboriginal health? Asian Pac J Cancer Prev. 2007;8:495–501.PubMed
15.
go back to reference Cramb SM, Garvey G, Valery PC, Williamson JD, Baade PD. The first year counts: cancer survival among Indigenous and non-Indigenous Queenslanders, 1997-2006. Med J Aust. 2012;196:270–4. Cramb SM, Garvey G, Valery PC, Williamson JD, Baade PD. The first year counts: cancer survival among Indigenous and non-Indigenous Queenslanders, 1997-2006. Med J Aust. 2012;196:270–4.
16.
go back to reference Moore SP, Green AC, Bray F, Garvey G, Coory M, Martin J, et al. Survival disparities in Australia: an analysis of patterns of care and comorbidities among Indigenous and non-Indigenous cancer patients. BMC Cancer. 2014;14:517. Moore SP, Green AC, Bray F, Garvey G, Coory M, Martin J, et al. Survival disparities in Australia: an analysis of patterns of care and comorbidities among Indigenous and non-Indigenous cancer patients. BMC Cancer. 2014;14:517.
17.
go back to reference Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008;9:585–95. Cunningham J, Rumbold AR, Zhang X, Condon JR. Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol. 2008;9:585–95.
18.
go back to reference Condon JR, Armstrong BK, Barnes A, Cunningham J. Cancer in Indigenous Australians: a review. Cancer Causes Control. 2003;14:109–21. Condon JR, Armstrong BK, Barnes A, Cunningham J. Cancer in Indigenous Australians: a review. Cancer Causes Control. 2003;14:109–21.
19.
go back to reference Gibberd A, Supramaniam R, Dillon A, Armstrong BK, O'Connell DL. Are Aboriginal people more likely to be diagnosed with more advanced cancer? Med J Aust. 2015;202:195–9.CrossRefPubMed Gibberd A, Supramaniam R, Dillon A, Armstrong BK, O'Connell DL. Are Aboriginal people more likely to be diagnosed with more advanced cancer? Med J Aust. 2015;202:195–9.CrossRefPubMed
20.
go back to reference Condon JR, Cunningham J, Barnes T, Armstrong BK, Selva-Nayagam S. Cancer diagnosis and treatment in the Northern Territory: assessing health service performance for Indigenous Australians. Intern Med J. 2006;36:498–505. Condon JR, Cunningham J, Barnes T, Armstrong BK, Selva-Nayagam S. Cancer diagnosis and treatment in the Northern Territory: assessing health service performance for Indigenous Australians. Intern Med J. 2006;36:498–505.
21.
go back to reference Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians, June 2011 ABS Cat. No. 3238.0.55.001. Canberra: ABS, 2013. Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians, June 2011 ABS Cat. No. 3238.0.55.001. Canberra: ABS, 2013.
22.
go back to reference Cancer Institute NSW. Cancer in NSW Aboriginal peoples: incidence, mortality and survival. Sydney: Cancer Institute NSW; 2012. Cancer Institute NSW. Cancer in NSW Aboriginal peoples: incidence, mortality and survival. Sydney: Cancer Institute NSW; 2012.
23.
go back to reference Barraclough H, Morrell S, Arcorace M, McElroy HJ, Baker DF. Degree-of-spread artefact in the New South Wales Central Cancer Registry. Aust N Z J Public Health. 2008;32:414–6. Barraclough H, Morrell S, Arcorace M, McElroy HJ, Baker DF. Degree-of-spread artefact in the New South Wales Central Cancer Registry. Aust N Z J Public Health. 2008;32:414–6.
24.
go back to reference Rodger JC, Supramaniam R, Gibberd AJ, Smith DP, Armstrong BK, Dillon A, et al. Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia. BJU Int. 2015;115:S16–23. Rodger JC, Supramaniam R, Gibberd AJ, Smith DP, Armstrong BK, Dillon A, et al. Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia. BJU Int. 2015;115:S16–23.
25.
go back to reference Moore SP, Green AC, Bray F, Coory M, Garvey G, Sabesan S, et al. Colorectal cancer among indigenous and non-Indigenous people in Queensland, Australia: toward survival equality. Asia Pac J Clin Oncol. 2014. doi:10.1111/ajco.12164. Moore SP, Green AC, Bray F, Coory M, Garvey G, Sabesan S, et al. Colorectal cancer among indigenous and non-Indigenous people in Queensland, Australia: toward survival equality. Asia Pac J Clin Oncol. 2014. doi:10.​1111/​ajco.​12164.
26.
go back to reference Cancer Institute NSW. Cancer in NSW Aboriginal peoples: completeness and quality of Aboriginal status data on the NSW Central Cancer Registry. Sydney: Cancer Institute NSW; 2012. Cancer Institute NSW. Cancer in NSW Aboriginal peoples: completeness and quality of Aboriginal status data on the NSW Central Cancer Registry. Sydney: Cancer Institute NSW; 2012.
27.
go back to reference World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 2000. World Health Organization. International Classification of Diseases for Oncology. Geneva: World Health Organization; 2000.
28.
go back to reference Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA). Revised ed. Canberra: Department of Health and Aged Care; 2001. Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA). Revised ed. Canberra: Department of Health and Aged Care; 2001.
29.
go back to reference Australian Bureau of Statistics. Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), 2006. ABS Cat. No. 2039.0. Canberra: ABS, 2008. Australian Bureau of Statistics. Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), 2006. ABS Cat. No. 2039.0. Canberra: ABS, 2008.
30.
go back to reference Esteban D, Whelan S, Laudico A, Parkin D. Manual for cancer registry personnel. IARC technical report no 10. International Agency for Research on Cancer: Lyon; 1995. Esteban D, Whelan S, Laudico A, Parkin D. Manual for cancer registry personnel. IARC technical report no 10. International Agency for Research on Cancer: Lyon; 1995.
31.
go back to reference Baraldi AN, Enders CK. An introduction to modern missing data analyses. J Sch Psychol. 2010;48:5–37.CrossRefPubMed Baraldi AN, Enders CK. An introduction to modern missing data analyses. J Sch Psychol. 2010;48:5–37.CrossRefPubMed
32.
go back to reference Stata Corp. Stata Multiple-Imputation Reference Manual Release 13. Texas: StataCorp LP; 2013. Stata Corp. Stata Multiple-Imputation Reference Manual Release 13. Texas: StataCorp LP; 2013.
33.
go back to reference Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.CrossRef Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.CrossRef
34.
go back to reference Fine JP, Gray R. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509. Fine JP, Gray R. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509.
37.
go back to reference Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63:64–71.CrossRefPubMed Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63:64–71.CrossRefPubMed
38.
go back to reference Reading CL, Wien F. Health inequalities and social determinants of Aboriginal Peoples' health. National Collaborating Centre for Aboriginal Health: Prince George, Bristish Columbia; 2009. Reading CL, Wien F. Health inequalities and social determinants of Aboriginal Peoples' health. National Collaborating Centre for Aboriginal Health: Prince George, Bristish Columbia; 2009.
39.
go back to reference Clark PJ, Stuart KA, Leggett BA, Crawford DH, Boyd P, Fawcett J, et al. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia. Liver Int. 2015;35:2584–94. Clark PJ, Stuart KA, Leggett BA, Crawford DH, Boyd P, Fawcett J, et al. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia. Liver Int. 2015;35:2584–94.
40.
go back to reference Christou A, Katzenellenbogen JM, Thompson SC. Australia's national bowel cancer screening program: does it work for Indigenous Australians? BMC Public Health. 2010;10:373. Christou A, Katzenellenbogen JM, Thompson SC. Australia's national bowel cancer screening program: does it work for Indigenous Australians? BMC Public Health. 2010;10:373.
41.
go back to reference Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584–98.CrossRefPubMedPubMedCentral Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584–98.CrossRefPubMedPubMedCentral
42.
go back to reference Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39:598–610.CrossRefPubMed Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39:598–610.CrossRefPubMed
44.
go back to reference Condon JR, Barnes T, Cunningham J, Armstrong BK. Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory. Med J Aust. 2004;180:504–7. Condon JR, Barnes T, Cunningham J, Armstrong BK. Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory. Med J Aust. 2004;180:504–7.
45.
go back to reference Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2012. Cat. No. CAN 70. Canberra: AIHW, 2012. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2012. Cat. No. CAN 70. Canberra: AIHW, 2012.
Metadata
Title
After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales
Authors
Hanna E. Tervonen
Richard Walton
Hui You
Deborah Baker
David Roder
David Currow
Sanchia Aranda
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3374-6

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine